Gangliosides in Orchestration of Intercellular Communication, Development, Neuronal Pathology and Carcinogenesis
-
Published:2022-02
Issue:1
Volume:53
Page:15-26
-
ISSN:1062-3604
-
Container-title:Russian Journal of Developmental Biology
-
language:en
-
Short-container-title:Russ J Dev Biol
Publisher
Pleiades Publishing Ltd
Subject
Developmental Biology
Reference66 articles.
1. Abe, A., Radin, N., Shayman, J., Worting, L., Zipkin, R., and Canem, B., Structural and stereochemical studies of potent inhibitors of glycosylceramide synthase and tumor cell growth, J. Lipid Res., 1995, vol. 36, pp. 611–621. 2. Alesenko, A.V., Zateishchikov, D.A., Lebedev, A.T., and Kurochkin, I.N., Involvement of sphingolipids in the pathogenesis of atherosclerosis, Kardiology, 2019, vol. 59, no. 8, pp. 77–87. 3. Barbour, S., Edidin, M., Felding-Habermann, B., Taylor-Norton, J., Radin, N.S., and Fenderson, B.A., Glycolipid depletion using a ceramide analogue (PDMP) alters growth, adhesion, and membrane lipid organization in human A431 cells, J. Cell Physiol., 1992, vol. 150, pp. 610–619. 4. Bergelson, L.D., Serum gangliosides as endogenous immunomodulators, Immunol. Today, 1995, vol. 16, pp. 483–486. 5. Bergelson, L.D., Dyatlovitskaya, E.V., Klyuchareva, T.E., Kryukova, E.V., Lemenovskaya, A.F., Matveeva, V.A., and Sinitsyna, E.V., The role of glycosphingolipids in natural immunity. Gangliosides modulate the cytotoxicity of natural killer cells, Eur. J. Immunol., 1989, vol. 19, pp. 1979–1983.
|
|